Literature DB >> 16563046

Reduced red blood cell destruction by antibody fragments.

A Mqadmi1, S Abramowitz, X Zheng, K Yazdanbakhsh.   

Abstract

Antibodies to blood group antigens can cause immune RBC destruction directly (extravascular destruction) or indirectly through subsequent complement activation (intravascular hemolysis). The Fc portion of the IgG antibody is responsible for the effector functions of immune RBC destruction. We hypothesized that sensitization of RBCs with blood group antigen-specific IgG antibodies lacking their Fc portion would escape from the recipient's immune system, allowing for a longer survival period of the RBCs in the circulation. Direct injection of mouse RBC-specific Ter-119 monoclonal antibody into mice resulted in a more severe anemia compared with that in mice injected with the Ter-119 F(ab')2 fragment. We found that mouse RBCs coated in vitro with the Ter-119 F(ab')2 fragment, when transfused into mice, survived longer in circulation compared with RBCs coated with whole Ter-119 IgG molecule. The data support the conclusion that antibodies can be rendered less pathogenic through removal of their Fc portion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563046      PMCID: PMC4797626     

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  7 in total

1.  [Elimination of rhesus (D)-incompatible erythrocytes by (Fab')2 G-anti-D (author's transl)].

Authors:  C Steenken; P Börner; P Mariss; K Heide; V Marks; I Schedel; H Deicher
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-10

2.  Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice.

Authors:  I Auffray; S Marfatia; K de Jong; G Lee; C H Huang; C Paszty; M J Tanner; N Mohandas; J A Chasis
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

3.  The binding site for C1q on IgG.

Authors:  A R Duncan; G Winter
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

4.  Mechanisms of red cell destruction mediated by non-complement binding IgG antibodies: the essential role in vivo of the Fc part of IgG.

Authors:  A E von dem Borne; D Beckers; C P Engelfriet
Journal:  Br J Haematol       Date:  1977-08       Impact factor: 6.998

5.  Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.

Authors:  H K Gold; L W Gimple; T Yasuda; R C Leinbach; W Werner; R Holt; R Jordan; H Berger; D Collen; B S Coller
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.

Authors:  Karina Yazdanbakhsh; Stanley Kang; Daniel Tamasauskas; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

7.  Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model.

Authors:  Michael B Jordan; Nico van Rooijen; Shozo Izui; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

  7 in total
  2 in total

1.  Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.

Authors:  Sergei Zaitsev; M Anna Kowalska; Michael Neyman; Ronald Carnemolla; Samira Tliba; Bi-Sen Ding; Aaron Stonestrom; Dirk Spitzer; John P Atkinson; Mortimer Poncz; Douglas B Cines; Charles T Esmon; Vladimir R Muzykantov
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

Review 2.  Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics.

Authors:  Patrick M Glassman; Carlos H Villa; Anvay Ukidve; Zongmin Zhao; Paige Smith; Samir Mitragotri; Alan J Russell; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Pharmaceutics       Date:  2020-05-09       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.